Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X; kConFab; Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL; OCGN; Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, Hamann U, Hogervorst FB, van Os TA, Gille HJ; HEBON; Peock S, Cook M, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Brewer C; EMBRACE; Hughes DJ, Coupier I, Giraud S, Coulet F, Colas C, Soubrier F, Rouleau E, Bièche I, Lidereau R, Demange L, Nogues C, Lynch HT; GEMO; Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Sutter C, Deissler H, Schaefer D, Froster UG; GC-HBOC; Aittomäki K, Nevanlinna H, McGuffog L, Easton DF, Chenevix-Trench G, Stoppa-Lyonnet D; Consortium of Investigators of Modifiers of BRCA1/2. Sinilnikova OM, et al. Among authors: dishon s. Br J Cancer. 2009 Oct 20;101(8):1456-60. doi: 10.1038/sj.bjc.6605279. Epub 2009 Aug 25. Br J Cancer. 2009. PMID: 19707196 Free PMC article.
BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L, Lejbkowicz F, Barnett-Griness O, Dishon S, Almog R, Rennert G. Raskin L, et al. Among authors: dishon s. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1617-23. doi: 10.1158/1055-9965.EPI-09-0060. Epub 2009 Apr 14. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19366906
BRCA1/2 mutation carriers: living with susceptibility.
Hagoel L, Neter E, Dishon S, Barnett O, Rennert G. Hagoel L, et al. Among authors: dishon s. Community Genet. 2003;6(4):242-8. doi: 10.1159/000079386. Community Genet. 2003. PMID: 15331870
Proband family uptake of familial-genetic counselling.
Hagoel L, Dishon S, Almog R, Silman Z, Bisland-Becktell S, Rennert G. Hagoel L, et al. Among authors: dishon s. Psychooncology. 2000 Nov-Dec;9(6):522-7. doi: 10.1002/1099-1611(200011/12)9:6<522::aid-pon492>3.0.co;2-s. Psychooncology. 2000. PMID: 11180587
Cancer genetics service provision: a comparison of seven European centres.
Hopwood P, van Asperen CJ, Borreani G, Bourret P, Decruyenaere M, Dishon S, Eisinger F, Evans DG, Evers-Kiebooms G, Gangeri L, Hagoel L, Legius E, Nippert I, Rennert G, Schlegelberger B, Sevilla C, Sobol H, Tibben A, Welkenhuysen M, Julian-Reynier C. Hopwood P, et al. Among authors: dishon s. Community Genet. 2003;6(4):192-205. doi: 10.1159/000079381. Community Genet. 2003. PMID: 15331865
32 results